ES2528494T3 - Forma de dosificación oral que comprende al menos un agente biológicamente activo, sustancias auxiliares de formulación y partículas magnetizables - Google Patents

Forma de dosificación oral que comprende al menos un agente biológicamente activo, sustancias auxiliares de formulación y partículas magnetizables Download PDF

Info

Publication number
ES2528494T3
ES2528494T3 ES10747220.1T ES10747220T ES2528494T3 ES 2528494 T3 ES2528494 T3 ES 2528494T3 ES 10747220 T ES10747220 T ES 10747220T ES 2528494 T3 ES2528494 T3 ES 2528494T3
Authority
ES
Spain
Prior art keywords
dosage form
phases
magnetic field
magnetized
magnetizable particles
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES10747220.1T
Other languages
English (en)
Spanish (es)
Inventor
Benedikt Hartwig
Norbert Windhab
Melanie Liefke
Juan Tome Alcalde
Michael Damm
Rosario Lizio
Michael Gottschalk
Angela Olf
Christian Meier
Andreas Gryczke
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roehm GmbH Darmstadt
Original Assignee
Evonik Roehm GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evonik Roehm GmbH filed Critical Evonik Roehm GmbH
Application granted granted Critical
Publication of ES2528494T3 publication Critical patent/ES2528494T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833—Encapsulating processes; Filling of capsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4883—Capsule finishing, e.g. dyeing, aromatising, polishing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5094—Microcapsules containing magnetic carrier material, e.g. ferrite for drug targeting

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ES10747220.1T 2009-09-03 2010-08-30 Forma de dosificación oral que comprende al menos un agente biológicamente activo, sustancias auxiliares de formulación y partículas magnetizables Active ES2528494T3 (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US239613P 2000-10-11
US23961309P 2009-09-03 2009-09-03
DE102009029170 2009-09-03
DE102009029170 2009-09-03
PCT/EP2010/062641 WO2011026808A1 (en) 2009-09-03 2010-08-30 Oral dosage form, comprising at least one biologically active agent, formulation auxiliary substances and magnetizable particles

Publications (1)

Publication Number Publication Date
ES2528494T3 true ES2528494T3 (es) 2015-02-10

Family

ID=42984007

Family Applications (1)

Application Number Title Priority Date Filing Date
ES10747220.1T Active ES2528494T3 (es) 2009-09-03 2010-08-30 Forma de dosificación oral que comprende al menos un agente biológicamente activo, sustancias auxiliares de formulación y partículas magnetizables

Country Status (13)

Country Link
US (1) US9050256B2 (enExample)
EP (1) EP2473095B1 (enExample)
JP (1) JP5868319B2 (enExample)
KR (1) KR101731130B1 (enExample)
CN (1) CN102573612B (enExample)
BR (1) BR112012004967B8 (enExample)
CA (1) CA2772708C (enExample)
ES (1) ES2528494T3 (enExample)
IL (1) IL217897A (enExample)
MX (1) MX2012002677A (enExample)
PL (1) PL2473095T3 (enExample)
SI (1) SI2473095T1 (enExample)
WO (1) WO2011026808A1 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103796626A (zh) * 2011-09-14 2014-05-14 佛罗里达大学 Smarttm固体口服剂型
DE102011089334A1 (de) 2011-12-21 2013-06-27 Evonik Röhm Gmbh Detektionssystem zur Erfassung magnetischer Objekte im menschlichen Organismus
US11667906B2 (en) * 2014-11-24 2023-06-06 Corning Incorporated Magnetic microcarriers
US11024449B2 (en) * 2017-06-06 2021-06-01 Apple Inc. Multipole elastomeric magnet with magnetic-field shunt
WO2019110321A1 (de) 2017-12-04 2019-06-13 Evonik Röhm Gmbh Maskierung und nachfolgende sichtbarmachung von esr signalen mittels der kombination von zwei materialien
US10824822B2 (en) * 2019-02-05 2020-11-03 International Business Machines Corporation Magnetic tracking for medicine management
US10679018B1 (en) 2019-02-05 2020-06-09 International Business Machines Corporation Magnetic tracking for medicine management
JP7502741B2 (ja) * 2019-09-26 2024-06-19 スピンセンシングファクトリー株式会社 磁気マーカーおよび磁気マーカー検出システム
AU2021356684A1 (en) 2020-10-09 2023-05-11 The Trustees Of The University Of Pennsylvania Compositions and methods for treatment of fabry disease
CN112360304A (zh) * 2020-11-06 2021-02-12 炫丽建材江苏有限公司 一种适用于22度免拉手门板的自愈合封边工艺
IL303390A (en) 2020-12-03 2023-08-01 Battelle Memorial Institute Compositions of polymer nanoparticles and DNA nanostructures and methods for non-viral transport
WO2022216977A1 (en) 2021-04-07 2022-10-13 Batelle Memorial Institute Rapid design, build, test, and learn technologies for identifying and using non-viral carriers
US20250250326A1 (en) 2022-04-06 2025-08-07 The Trustees Of The University Of Pennsylvania Passive immunization with anti-aav neutralizing antibodies to prevent off-target transduction of intrathecally delivered aav vectors
CA3247109A1 (en) 2022-04-06 2023-10-12 The Trustees Of The University Of Pennsylvania Compositions and treatment methods for metastatic breast cancer that is human epidermal growth factor receptor 2 positive and other cancers
WO2025072751A1 (en) 2023-09-29 2025-04-03 Battelle Memorial Institute Polymer nanoparticle compositions for in vivo expression of polypeptides
AU2024393766A1 (en) 2023-12-08 2026-06-18 Battelle Memorial Institute Use of dna origami nanostructures for molecular information based data storage systems

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3723310A1 (de) * 1987-07-15 1989-01-26 John Urquhart Pharmazeutisches praeparat und verfahren zu seiner herstellung
DE3740187A1 (de) 1987-11-27 1989-06-08 Urquhart John Verfahren und vorrichtung zum ueberwachen und/oder kontrollieren und/oder registrieren und/oder anzeigen der einnahme von pharmazeutischen praeparaten
DE3940260A1 (de) 1989-03-04 1990-09-13 Werner Weitschies Verfahren zur bestimmung des aufenthaltsortes und der bewegung von objekten durch ihre markierung als magnetisches moment
CN1056049C (zh) * 1994-02-02 2000-09-06 湖南省商业科技研究所 一种磁疗食品的制备方法
EP0928155A1 (de) 1996-08-16 1999-07-14 Roche Diagnostics GmbH Kontrollsystem für die überwachung der regelmässigen einnahme eines medikamentes
JP2004331750A (ja) 2003-05-02 2004-11-25 Canon Inc ポリヒドロキシアルカノエートを含有する磁性構造体及びその製造方法ならびにその用途
EP1557151A1 (en) * 2004-01-22 2005-07-27 F. Hoffmann-La Roche Ag Solid dosage form
CN100355454C (zh) 2005-10-25 2007-12-19 南京工业大学 磁热疗用纳米磁粉－抗人肝癌单抗HAb18靶向药物
EP1880716A1 (en) 2006-07-19 2008-01-23 Sandoz AG Kit of parts comprising an acid labile and an acid resistant pharmaceutically active ingredient
DE102008033662A1 (de) 2008-07-11 2010-01-14 Technische Universität Ilmenau Pharmakologische Darreichungsform und Vorrichtung und Verfahren zur kontinuierlichen Lokalisierung und Verfolgung des Auflösevorganges dieser

Also Published As

Publication number Publication date
CA2772708C (en) 2017-07-11
KR101731130B1 (ko) 2017-05-11
BR112012004967B1 (pt) 2021-05-11
SI2473095T1 (sl) 2015-02-27
US9050256B2 (en) 2015-06-09
IL217897A0 (en) 2012-03-29
IL217897A (en) 2014-06-30
US20120143039A1 (en) 2012-06-07
CN102573612B (zh) 2015-07-08
JP2013503831A (ja) 2013-02-04
JP5868319B2 (ja) 2016-02-24
EP2473095A1 (en) 2012-07-11
EP2473095B1 (en) 2014-11-12
CN102573612A (zh) 2012-07-11
MX2012002677A (es) 2012-04-11
CA2772708A1 (en) 2011-03-10
KR20120060210A (ko) 2012-06-11
BR112012004967B8 (pt) 2022-07-05
WO2011026808A1 (en) 2011-03-10
HK1168016A1 (en) 2012-12-21
WO2011026808A8 (en) 2012-03-15
BR112012004967A2 (pt) 2016-04-05
PL2473095T3 (pl) 2015-04-30

Similar Documents

Publication Publication Date Title
JP5868319B2 (ja) １つ以上の生物学的活性物質、調合補助物質および磁化可能粒子を包含する経口剤形
Fadda et al. Meal-induced acceleration of tablet transit through the human small intestine
Sonaje et al. Enteric-coated capsules filled with freeze-dried chitosan/poly (γ-glutamic acid) nanoparticles for oral insulin delivery
ES2614057T3 (es) Sistema de detección para la detección de objetos magnéticos en el organismo humano
AU2002317466B2 (en) Device and method for examining a body lumen
Jones et al. The disintegration behaviour of capsules in fed subjects: a comparison of hypromellose (carrageenan) capsules and standard gelatin capsules
BRPI0213175B1 (pt) Oral galenical form macroparticulate for delayed and controlled release of a pharmaceutical active principles and use of microcapsules "reservoir"
Jang et al. Size discrimination in rat and mouse gastric emptying
US12383495B2 (en) Resident articles for gram-level dosing
ES2149733T5 (es) Composicion farmaceutica oral de liberacion modificada que contiene 5-asa y metodo para el tratamiento de enfermedades intestinales.
Razavi et al. An overview on floating drug delivery systems (FDDS); conventional and new approaches for preparation and in vitro–in vivo evaluation
Kenyon et al. The effect of food on the in vivo behaviour of enteric coated starch capsules
Wilding et al. Scintigraphic and pharmacokinetic assessment of a multiparticulate sustained release formulation of diltiazem
Burke et al. A novel method to radiolabel gastric retentive formulations for gamma scintigraphy assessment
Singh et al. Gastroretentive drug delivery systems
Krishna et al. Strategic approaches and evaluation of gastro retentive drug delivery system-A Review
HK1168016B (en) Oral dosage form, comprising at least one biologically active agent, formulation auxiliary substances and magnetizable particles
Arora et al. Radiopharmaceutical-based approaches for the determination of colon-targeting efficiency
J. McInnes et al. IN VIVO IMAGING FOR VALIDATION OF ORAL DOSE PERFORMANCE
Hodges In Vivo Characterization of Oral Multiparticulate Systems
Rezaeifar Multiparticulate systems based on enteric polymers
Cora et al. Magnetic images with a biosusceptometer of pharmaceutical dosage forms in the human gastrointestinal tract
Reshma Formulation and Evaluation of Olmesartan Medoxomil Pulsatile Drug Delivery System
Shehu et al. Status of Oral Chronopharmaceuticals Drug Delivery System, Latest Technologies, and Hurdles